By the same authors

From the same journal

Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic

Research output: Contribution to journalArticlepeer-review



Publication details

DateAccepted/In press - 3 Aug 2017
DateE-pub ahead of print (current) - 2 Nov 2017
Issue number7
Number of pages11
Pages (from-to)853-864
Early online date2/11/17
Original languageEnglish


This paper asks how regenerative medicine can be examined through the ‘responsible research and innovation’ (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a ‘responsible acceleration’, more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.

Bibliographical note

© 2017 Future Science Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.


Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations